| Literature DB >> 35362451 |
Ju Yup Lee1, Chul-Hyun Lim2, Do Hoon Kim3, Hwoon-Yong Jung3, Young Hoon Youn4, Da Hyun Jung5, Jun Chul Park5, Hee Seok Moon6, Su Jin Hong7.
Abstract
Background/Aims: To analyze various adverse events (AEs) related to the peroral endoscopic myotomy (POEM) procedure and to analyze whether these AEs are related to an extended hospital stay.Entities:
Keywords: Achalasia; Adverse events; Endoscopic myotomy; Esophageal motility disorder; Hospital stay
Year: 2022 PMID: 35362451 PMCID: PMC8978124 DOI: 10.5056/jnm21081
Source DB: PubMed Journal: J Neurogastroenterol Motil ISSN: 2093-0879 Impact factor: 4.924
Patient Characteristics
| Variables | N = 328 |
|---|---|
| Age (yr) | 50.0 ± 17.2 |
| Sex (M/F) | 164/164 |
| Previous illness | |
| None | 177 (59.8) |
| Hypertension | 48 (16.2) |
| Diabetes mellitus | 23 (7.8) |
| Others | 58 (19.6) |
| Medication history | |
| None | 249 (84.1) |
| Anti-platelets | 12 (4.1) |
| Warfarin | 2 (0.7) |
| NOAC | 2 (0.7) |
| Steroids | 2 (0.7) |
| Others | 10 (3.4) |
| Diagnosis | |
| Type I | 121 (36.9) |
| Type II | 138 (42.1) |
| Type III | 48 (14.6) |
| Distal esophageal spasm | 4 (1.2) |
| Jackhammer esophagus | 4 (1.2) |
| EGJ outflow obstruction | 6 (1.8) |
| Unclassified (manometry fail, etc) | 7 (2.1) |
| Previous treatment | |
| Naïve | 242 (73.8) |
| Balloon dilatation | 64 (19.5) |
| Botox injection | 12 (3.7) |
| Heller’s myotomy | 5 (1.5) |
| POEM | 5 (1.5) |
| Esophageal myotomy length (cm) | 8.5 (6.2-10.0) |
| Gastric myotomy length (cm) | 3.0 (2.0-3.0) |
| POEM procedure time (min) | 70.0 (55.0-87.0) |
| Length of hospital stay after POEM (days) | 5.0 (4.0-6.0) |
| Meaningful discharge delay due to adverse events | 43 (13.1) |
aHeart disease (coronary artery disease, atrial fibrillation, and congestive heart failure), cerebrovascular disease (cerebrovascular accident and Parkinson’s disease), etc.
M, male; F, female; NOAC, novel oral anti-coagulant; EGJ, esophagogastric junction; POEM, peroral endoscopic myotomy.
Data are presented as mean ± SD, n, n (%), or median (interquartile range [IQR]).
FigureMajor adverse events during or after peroral endoscopic myotomy (POEM) that included mucosal injury (A, B), bleeding (C, D), and hemothorax (E-H). Gastric mucosa (cardia) laceration during POEM (A), clipping site mucosal perforation (B), incision site bleeding (C) with exposed vessel (D), chest X-ray performed due to severe chest pain 2 days after POEM and showing mediastinum widening (E), CT scan showing an esophageal rupture with hemothorax (F), endoscopy revealing large submucosal tunnel hematoma (G), immediately after insertion of the chest tube, 700 mL of blood was drained (H).
Analysis of the Frequency of Peroral Endoscopic Myotomy Adverse Events
| Adverse events | n (%) |
|---|---|
| None | 207 (63.1) |
| Major | |
| Mucosal injury | 5 (1.5) |
| Bleeding | 2 (0.6) |
| Hemothorax | 1 (0.3) |
| Minor | |
| Gas-related | |
| Pneumoperitoneum | 51 (15.5) |
| Subcutaneous emphysema | 16 (4.9) |
| Pneumomediastinum | 6 (1.8) |
| Pneumoretroperitoneum | 2 (0.6) |
| Not related to gas | |
| Pneumonia | 15 (4.6) |
| Pain | 9 (2.7) |
| Fever | 8 (2.4) |
| Pleural effusion | 3 (0.9) |
| Others | |
| Diarrhea | 2 (0.6) |
| Pharyngeal laceration | 1 (0.3) |
| Total | 328 (100.0) |
Comparison of Delayed and No Delayed Discharge Groups
| Variables | No delayed discharge (n = 285) | Delayed discharge (n = 43) | |
|---|---|---|---|
| Age (yr) | 50.1 ±17.2 | 50.0 ± 17.0 | 0.965 |
| Sex (M/F) | 141/144 | 23/20 | 0.624 |
| Previous illness | 0.302 | ||
| None | 150 (52.6) | 27 (62.8) | |
| HTN | 36 (12.6) | 12 (27.9) | |
| DM | 20 (7.0) | 3 (7.0) | |
| Others | 45 (15.8) | 13 (30.2) | |
| Previous medical history | 0.614 | ||
| None | 205 (71.9) | 36 (83.7) | |
| Anti-platelet | 9 (3.2) | 3 (7.0) | |
| Warfarin | 1 (0.4) | 1 (2.3) | |
| NOAC | 2 (0.7) | 0 (0.0) | |
| Steroid | 1 (0.4) | 1 (2.3) | |
| Others | 8 (2.8) | 2 (4.6) | |
| Diagnosis | 0.727 | ||
| Type I | 108 (37.9) | 13 (30.2) | |
| Type II | 116 (40.7) | 22 (51.2) | |
| Type III | 41 (14.4) | 7 (16.3) | |
| Distal esophageal spasm | 4 (1.4) | 0 (0.0) | |
| Jackhammer esophagus | 4 (1.4) | 0 (0.0) | |
| EGJ outflow obstruction | 5 (1.8) | 1 (2.3) | |
| Unclassified (manometry fail, etc) | 7 (2.5) | 0 (0.0) | |
| Previous treatment | 0.655 | ||
| Naïve | 206 (73.6) | 36 (75.0) | |
| Balloon dilatation | 53 (18.9) | 11 (22.9) | |
| Botox injection | 11 (3.9) | 1 (2.1) | |
| Heller’s myotomy | 5 (1.8) | 0 (0.0) | |
| POEM | 5 (1.8) | 0 (0.0) | |
| Esophageal myotomy length (cm) | 9.0 (6.0-10.0) | 8.0 (7.0-10.0) | 0.509 |
| Gastric myotomy length (cm) | 3.0 (2.0-3.0) | 3.0 (2.0-3.0) | 0.739 |
| POEM procedure time (min) | 68.0 (54.0-85.3) | 70.0 (56.7-99.2) | 0.261 |
| Hospital admission after POEM (day) | 4.0 (3.0-5.0) | 6.0 (5.0-8.0) | < 0.001 |
M, male; F, female; HTN, hypertension; DM, diabetes mellitus; NOAC, novel oral anticoagulants; EGJ, esophagogastric junction; POEM, peroral endoscopic myotomy.
Data are presented as mean ± SD, n, n (%), or median (interquartile range [IQR]).
Meaningful Delayed Discharge Compared to No Delayed Discharge Group
| Adverse events | n (%) | Meaningful delayed discharge (n) | Admission period after POEM (day) | Median differences | |
|---|---|---|---|---|---|
| None | 207 (63.1) | 0 | 4.0 (3.0-5.0) | ||
| Major | |||||
| Nucosal injury | 5 (1.5) | 4 | 14.5 (12.4-23.0) | 9.0 (7.0-13.0) | 0.008 |
| Bleeding | 2 (0.6) | 2 | 10.0 (6.0-14.0) | 4.5 (1.0-11.0) | 0.017 |
| Hemothorax | 1 (0.3) | 1 | 13.0 (13.0-13.0) | 9.0 | 0.072 |
| Minor | |||||
| Gas-related | |||||
| Pneumoperitoneum | 51 (15.5) | 0 | 5.0 (4.0-6.0) | 1.0 (0.0-1.0) | < 0.001 |
| Subcutaneous Emphysema | 16 (4.9) | 4 | 6.0 (6.0-7.6) | 3.0 (2.0-3.0) | < 0.001 |
| Pneumomediastinum | 6 (1.8) | 0 | 4.5 (3.0-6.1) | 0.0 (–1.0-2.0) | 0.479 |
| Pneumoretroperitoneum | 2 (0.6) | 0 | 4.0 (3.0-5.0) | 1.0 (0.0-2.0) | 0.155 |
| Non-gas- related | |||||
| Pneumonia | 15 (4.6) | 11 | 6.0 (5.0-7.0) | 2.0 (1.0-3.0) | < 0.001 |
| Pain | 9 (2.7) | 9 | 5.0 (5.0-7.0) | 2.0 (1.0-2.0) | 0.001 |
| Fever | 8 (2.4) | 8 | 6.0 (5.0-6.6) | 2.0 (1.0-3.0) | < 0.001 |
| Pleural effusion | 3 (0.9) | 1 | 8.0 (5.5-8.8) | 4.0 (1.0-5.0) | 0.009 |
| Others | |||||
| Diarrhea | 2 (0.6) | 2 | 5.5 (5.0-6.0) | 1.0 (0.0-3.0) | 0.068 |
| Pharynx laceration | 1 (0.3) | 1 | 7.0 (7.0-7.0) | 3.0 | 0.080 |
| Total | 328 (100.0) | 43 | 5.0 (4.0-6.0) |
aCompare with no adverse events group, Hodges-Lehmann location shift (95% CI).
b95% CI cannot be obtained since n = 1.
Data are presented as n (%) or median (interquartile range).